| Citation: |
YU Jie, YANG Feng, DENG Jian, HU Linwang. Knockdown of DCLK1 Inhibits Proliferation, Migration and Invasion of Glioma Cells[J]. Cancer Research on Prevention and Treatment, 2020, 47(9): 655-659. DOI: 10.3971/j.issn.1000-8578.2020.20.0127
|
To investigate the effects of DCLK1 on the proliferation, migration and invasion of glioma cells and their mechanisms.
The mRNA and protein expression of DCLK1 in glioma tissues and glioma cell lines U87 and A172 were detected by RT-qPCR, immunohistochemical staining and Western blot. sh-DCLK1 and the corresponding negative control (sh-Con) were transfected into glioma cell lines U87 and A172 by Lipofectamine 2000 to silence DCLK1 expression. The effects of DCLK1 knockdown on the proliferation, migration and invasion of glioma cells were analyzed by MTT assay and Transwell assay. The effects of DCLK1 knockdown on the expression of TGF-β/Smads signaling pathway-related proteins TGF-β1, p-Smad2 and p-Smad7 in glioma cells were detected by Western blot. U87 cells transfected with sh-DCLK1 or sh-Con were injected into the subcutaneous neck of BALB/c nude mice, the tumor volume and weight were measured.
Compared with normal adjacent tissues and normal glial cells, the mRNA and protein expression levels of DCLK1 were significantly increased in glioma tissues and cells (P < 0.001). Compared with sh-Con group, the proliferation, migration and invasion abilities, and the expressions of TGF-β1, p-Smad2 and p-Smad7 proteins of glioma cells in sh-DCLK1 group were significantly decreased (P < 0.01; P < 0.001); in addition, tumor volume and weight of sh-DCLK1 group were significantly reduced in vivo (P < 0.001).
DCLK1 knockdown could inhibit the proliferation, migration and invasion of glioma cells, which may be related to the inhibition of TGF-β/Smads signal activity.
| [1] |
de Robles P, Fiest KM, Frolkis AD, et al. The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis[J]. Neuro Oncol, 2015, 17(6): 776-783. http://intl-neuro-oncology.oxfordjournals.org/content/17/6/776
|
| [2] |
Lara-Velazquez M, Al-Kharboosh R, Jeanneret S, et al. Advances in brain tumor surgery for glioblastoma in adults[J]. Brain Sci, 2017, 7(12): 166. doi: 10.3390/brainsci7120166
|
| [3] |
Soomro SH, Ting LR, Qing YY, et al. Molecular biology of glioblastoma: Classification and mutational locations[J]. J Pak Med Assoc, 2017, 67(9): 1410-1414. http://www.ncbi.nlm.nih.gov/pubmed/28924284
|
| [4] |
Wang YL, Li Y, Ma YG, et al. DCLK1 promotes malignant progression of breast cancer by regulating Wnt/β-Catenin signaling pathway[J]. Eur Rev Med Pharmacol Sci, 2019, 23(21): 9489-9498. http://www.researchgate.net/publication/337604609_DCLK1_promotes_malignant_progression_of_breast_cancer_by_regulating_Wntb-Catenin_signaling_pathway
|
| [5] |
Fan M, Qian N, Dai G. Expression and prognostic significance of doublecortin-like kinase 1 in patients with hepatocellular carcinoma[J]. Oncol Lett, 2017, 14(6): 7529-7537. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=fbwk201801015
|
| [6] |
Gzil A, Szylberg Ł, Jaworski D, et al. The essential role of DCLK1 in pathogenesis, diagnostic procedures and prognostic stratification of colorectal cancer[J]. Anticancer Res, 2019, 39(6): 2689-2697. doi: 10.21873/anticanres.13394
|
| [7] |
Qu D, Johnson J, Chandrakesan P, et al. Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells[J]. PLoS One, 2015, 10(2): e0118933. doi: 10.1371/journal.pone.0118933
|
| [8] |
Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review[J]. JAMA, 2013, 310(17): 1842-1850. doi: 10.1001/jama.2013.280319
|
| [9] |
Davis ME. Glioblastoma: overview of disease and treatment[J]. Clin J Oncol Nurs, 2016, 20(5 Suppl): S2-S8.
|
| [10] |
Verissimo CS, Molenaar JJ, Fitzsimons CP, et al. Neuroblastoma therapy: what is in the pipeline[J]. Endocr Relat Cancer, 2011, 18(6): R213-R231. doi: 10.1530/ERC-11-0251
|
| [11] |
Xia X, He C, Wu A, et al. Microtubule-associated protein 4 is a prognostic factor and promotes tumor progression in lung adenocarcinoma[J]. Dis Markers, 2018, 2018: 8956072. http://europepmc.org/abstract/MED/29743960
|
| [12] |
Li J, Wang Y, Ge J, et al. Doublecortin-like kinase 1(DCLK1) regulates B Cell-specific moloney murine leukemia virus insertion site 1(Bmi-1) and is associated with metastasis and prognosis in pancreatic cancer[J]. Cell Physiol Biochem, 2018, 51(1): 262-277.
|
| [13] |
Wang J, Li Y, Wang X, et al. Ursolic acid inhibits proliferation and induces apoptosis in human glioblastoma cell lines U251 by suppressing TGF-β1/miR-21/PDCD4 pathway[J]. Basic Clin Pharmacol Toxicol, 2012, 111(2): 106-112. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=26d881dbe82aeb39e3fde9262c4ecb22
|
| [14] |
陈玉红, 狄翠霞, 张倩婧, 等. TGF-β/Smads信号传导通路在肿瘤中的作用[J].生理科学进展, 2018, 49(3): 187-192. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=slkxjz201803006
Chen YH, Di CX, Zhang QJ, et al. The role of TGF-β/Smads signaling pathway in tumors[J]. Sheng Li Ke Xue Jin Zhan, 2018, 49(3): 187-192. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=slkxjz201803006
|
| [15] |
Chandrakesan P, Roy B, Jakkula LU, et al. Utility of a bacterial infection model to study epithelial-mesenchymal transition, mesenchymal-epithelial transition or tumorigenesis[J]. Oncogene, 2014, 33(20): 2639-2654. doi: 10.1038/onc.2013.210
|
| [16] |
Tao S, Liu M, Shen D, et al. TGF-β/Smads signaling affects radiation response and prolongs survival by regulating DNA repair genes in malignant glioma[J]. DNA Cell Biol, 2018, 37(11): 909-916. doi: 10.1089/dna.2018.4310
|
| [17] |
Guan F, Kang Z, Wang L, et al. Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-β/SMAD signaling pathway[J]. Chin Med J (Engl), 2019, 132(20): 2430-2437. doi: 10.1097/CM9.0000000000000478
|
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: